|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Turion Labs lunches in Singapore to power Southeast Asia’s biotech breakthroughs
|
|
Friday, 09 May, 2025, 16 : 00 PM [IST]
|
|
Singapore
|
Turion Labs, a pioneering biotech venture formed by S&S LAB Korea and Future Lestari (Indonesia), officially launched in Singapore during Ecosperity Week, unveiling a transformative vision to position Southeast Asia as a global innovation engine for medical and life sciences.
Designed as the region’s first full-stack biotech innovation platform, it integrates shared laboratory infrastructure, contract research services (CRO), and regulatory enablement into a unified solution that supports biomedtech ventures from discovery to commercialisation.
Dominic Jeong, CEO of S&S LAB Korea, said, “We’re bridging the gap between high-potential science and scalable solutions. With Southeast Asia as our launchpad, we are building a connected platform that empowers global biotech innovators to gain access to Korean R&D excellence, Southeast Asian market pathways, and world-class lab infrastructure.”
Turion Labs’ first major facility is set to open later this year at the Sinarmas Land Biomedical Hub in BSD City, Indonesia — a newly designated Biomedical Special Economic Zone. This flagship site will host modular labs, pilot-scale research suites, and clinical support services, creating a powerful springboard for biotech development and commercialisation.
Cynthia Krisanti, director of Future Lestari, said, “Turion Labs is a platform for acceleration — a place where biotech ideas become real-world impact. We are creating a robust ecosystem for regional and global innovators, enabling faster product development, streamlined regulation, and expanded market access, all rooted in Southeast Asia.”
|
|
|
|
|
|
|
|
|
|